Skip to main content
. 2024 Apr 22;9(4):e014188. doi: 10.1136/bmjgh-2023-014188

Figure 8.

Figure 8

COVID-19 case management guideline for home-based care in Myanmar elaborated by WHO in 2021 . In Myanmar, with the exception of a limited supplementary oxygen availability and corticosteroids, these recommended therapeutic interventions were generally unavailable within the country, and tocilizumab, baracitinib and neutralising monoclonal antibodies were not available at all.